Google+ Facebook Twitter Twitter

Gastrointestinal tumour recurrence

US researchers have identified a new feature indicative of the chance of recurrence of gastrointestinal stromal tumours (GISTs).

Clinicians currently rely on examining the prognostic features of location, size and mitotic activity.

But researchers have now identified mucosal ulcerations as a potential fourth feature that could play a role in indicating the chance of recurrence.

“Our findings indicate that ulceration is an independent predictor of the three known features experts use in risk stratification of GISTs,” said Martin McCarter, lead author. “This finding is significant because it’s new information that might change the future of treatment of this tumour.”

The team examined a database of patients diagnosed with GISTs and completed a chart review to determine the occurrence rate of ulcerations in addition to the other pathological indicators.

Of 310 patients reviewed, 85 had mucosal ulceration with their GIST. Researchers found that patients with ulcerated GIST were more likely to experience disease progression.

Related Articles

Transforming histopathology

Following a complete overhaul, one lab is on track to hit the 98% target for 10-day turnaround times by 2025. Quality, Training and Transformation Manager Paul Chenery talks through the ambitious journey.

Digital pathology: a white paper

A look at the new IBMS and Microsoft white paper Digital Pathology and Integrated Care Systems, which was launched in September.

"No improvements for colonoscopies with AI"

A randomised controlled trial found that colonoscopy assisted by computer-aided detection (CAD) was not associated with improved detection of advanced colorectal neoplasias.

The big question: IBMS Congress 2023

This month we ask “What makes Congress the ‘go-to’ event for you?”